The fastest reviews I did had one thing in common, and it wasn't the p-value.
It was whether the protocol, the SAP and the reported results told one story.
More in Issue 1 of The Significant Difference ↓
thesignificantdifference.com
The first thing an FDA statistician looks for (it's not the p-value)
What FDA's reviewers see — and what sponsors need to know